Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation
Introduction: The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and...
Gespeichert in:
Veröffentlicht in: | The journal of vascular access 2021-05, Vol.22 (3), p.370-379 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 379 |
---|---|
container_issue | 3 |
container_start_page | 370 |
container_title | The journal of vascular access |
container_volume | 22 |
creator | Jiménez Hernández, Mario Soriano, Alex Filella, Xavier Calvo, María Coll, Elisenda Rebled, Josep M Poch, Esteban Graterol, Fredzia Compte, María Teresa Maduell, Francisco Fontsere, Néstor |
description | Introduction:
The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and potentially increase patients’ inflammatory response. These complications could be reduced by the use of locking solutions.
Objective:
To analyse biofilm formation, using confocal and electron microscopy, in tunnelled cuffed catheters locked with three different solutions and to determine the relationship between these solutions and inflammatory response.
Study design:
This prospective study included 35 haemodialysis patients with tunnelled cuffed catheter removal for non–infection-related reasons. The participants were divided into three groups according to the lock solution used: (1) heparin 1: 5000 IU; (2) citrate 4%; and (3) taurolidine 1.35%, citrate 4% and heparin 500 IU (taurolock); in the latter group, 25,000 IU taurolidine–urokinase was used in the last weekly session. All tunnelled cuffed catheters were cultured, and the inner surface was evaluated with confocal and electron microscopy. The inflammatory profile of included patients was determined at tunnelled cuffed catheter removal.
Results:
There were no differences in clinical or demographic variables between the three subgroups. Biofilm thickness was lower in the taurolidine group than in the citrate 4% and heparin groups (28.85 ± 6.86 vs 49.99 ± 16.56 vs 56.2 ± 15.67 µm, respectively; p |
doi_str_mv | 10.1177/1129729820942040 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2425902953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1129729820942040</sage_id><sourcerecordid>2425902953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-9232717827aa418a1dc46b83ab5bc53635d78ba4eb263d31359fb4be35e9f363</originalsourceid><addsrcrecordid>eNp1kLtOwzAYhS0EoqWwMyGPLAHfEscjqrhUqsTSPbIdp3VJ7GInSH0CXhuHFgYkJl_OOd9vHwCuMbrDmPN7jIngRJQECUYQQydgijlhWYEoOU37JGejPgEXMW4RIiLH7BxMKCkELop8Cj4X3U7qHvoGtl6_WbeG0bdDb72L0DuovavteBoVZX1j2w42PnRyvITWwX5wzrStqeFGms7XVrb7aCPUst-Y3oQIpauTsWlll1I-7GEwcZf4BqbJ9uObdAnOGtlGc3VcZ2D19Liav2TL1-fF_GGZaUp5nwlCCce8JFxKhkuJa80KVVKpcqVzWtC85qWSzChS0JpimotGMWVobkST5Bm4PWB3wb8PJvZVZ6NOz5fO-CFWhJFcjDXRZEUHqw4-xmCaahdsJ8O-wqga26_-tp8iN0f6oDpT_wZ-6k6G7GCIcm2qrR-CS5_9H_gFjDuP1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425902953</pqid></control><display><type>article</type><title>Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation</title><source>MEDLINE</source><source>SAGE Journals Online</source><creator>Jiménez Hernández, Mario ; Soriano, Alex ; Filella, Xavier ; Calvo, María ; Coll, Elisenda ; Rebled, Josep M ; Poch, Esteban ; Graterol, Fredzia ; Compte, María Teresa ; Maduell, Francisco ; Fontsere, Néstor</creator><creatorcontrib>Jiménez Hernández, Mario ; Soriano, Alex ; Filella, Xavier ; Calvo, María ; Coll, Elisenda ; Rebled, Josep M ; Poch, Esteban ; Graterol, Fredzia ; Compte, María Teresa ; Maduell, Francisco ; Fontsere, Néstor</creatorcontrib><description>Introduction:
The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and potentially increase patients’ inflammatory response. These complications could be reduced by the use of locking solutions.
Objective:
To analyse biofilm formation, using confocal and electron microscopy, in tunnelled cuffed catheters locked with three different solutions and to determine the relationship between these solutions and inflammatory response.
Study design:
This prospective study included 35 haemodialysis patients with tunnelled cuffed catheter removal for non–infection-related reasons. The participants were divided into three groups according to the lock solution used: (1) heparin 1: 5000 IU; (2) citrate 4%; and (3) taurolidine 1.35%, citrate 4% and heparin 500 IU (taurolock); in the latter group, 25,000 IU taurolidine–urokinase was used in the last weekly session. All tunnelled cuffed catheters were cultured, and the inner surface was evaluated with confocal and electron microscopy. The inflammatory profile of included patients was determined at tunnelled cuffed catheter removal.
Results:
There were no differences in clinical or demographic variables between the three subgroups. Biofilm thickness was lower in the taurolidine group than in the citrate 4% and heparin groups (28.85 ± 6.86 vs 49.99 ± 16.56 vs 56.2 ± 15.67 µm, respectively; p < 0.001), as was biofilm volume (1.01 ±1.18 vs 3.7 ± 2.15 vs 5.55 ±2.44, µm3, respectively; p < 0.001). The mean interleukin-6 value was 39%, which was 50% lower than in the citrate and heparin groups, but without significance differences.
Conclusion:
Our results show that biofilms were found in all tunnelled cuffed catheters, but the thickness and volume were significantly lower in tunnelled cuffed catheters locked with taurolidine solution. Therefore, the type of locking solution used in tunnelled cuffed catheters should maintain tunnelled cuffed catheter sterility and prevent catheter-related bloodstream infections. No significant difference was observed in the inflammatory profile according to the type of locking solution.</description><identifier>ISSN: 1129-7298</identifier><identifier>EISSN: 1724-6032</identifier><identifier>DOI: 10.1177/1129729820942040</identifier><identifier>PMID: 32691665</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject><![CDATA[Adult ; Aged ; Aged, 80 and over ; Anti-Infective Agents - administration & dosage ; Anti-Infective Agents - adverse effects ; Anticoagulants - administration & dosage ; Anticoagulants - adverse effects ; Biofilms - drug effects ; Biofilms - growth & development ; Catheter-Related Infections - diagnosis ; Catheter-Related Infections - microbiology ; Catheter-Related Infections - prevention & control ; Catheters, Indwelling ; Citric Acid - administration & dosage ; Citric Acid - adverse effects ; Equipment Design ; Female ; Heparin - administration & dosage ; Heparin - adverse effects ; Humans ; Inflammation - blood ; Inflammation - etiology ; Inflammation - prevention & control ; Inflammation Mediators - blood ; Interleukin-6 - blood ; Male ; Microscopy, Confocal ; Microscopy, Electron, Scanning ; Middle Aged ; Pilot Projects ; Prospective Studies ; Renal Dialysis - adverse effects ; Renal Dialysis - instrumentation ; Surface Properties ; Taurine - administration & dosage ; Taurine - adverse effects ; Taurine - analogs & derivatives ; Thiadiazines - administration & dosage ; Thiadiazines - adverse effects ; Time Factors ; Treatment Outcome]]></subject><ispartof>The journal of vascular access, 2021-05, Vol.22 (3), p.370-379</ispartof><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-9232717827aa418a1dc46b83ab5bc53635d78ba4eb263d31359fb4be35e9f363</citedby><cites>FETCH-LOGICAL-c337t-9232717827aa418a1dc46b83ab5bc53635d78ba4eb263d31359fb4be35e9f363</cites><orcidid>0000-0002-3704-7318</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1129729820942040$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1129729820942040$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21799,27903,27904,43600,43601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32691665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jiménez Hernández, Mario</creatorcontrib><creatorcontrib>Soriano, Alex</creatorcontrib><creatorcontrib>Filella, Xavier</creatorcontrib><creatorcontrib>Calvo, María</creatorcontrib><creatorcontrib>Coll, Elisenda</creatorcontrib><creatorcontrib>Rebled, Josep M</creatorcontrib><creatorcontrib>Poch, Esteban</creatorcontrib><creatorcontrib>Graterol, Fredzia</creatorcontrib><creatorcontrib>Compte, María Teresa</creatorcontrib><creatorcontrib>Maduell, Francisco</creatorcontrib><creatorcontrib>Fontsere, Néstor</creatorcontrib><title>Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation</title><title>The journal of vascular access</title><addtitle>J Vasc Access</addtitle><description>Introduction:
The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and potentially increase patients’ inflammatory response. These complications could be reduced by the use of locking solutions.
Objective:
To analyse biofilm formation, using confocal and electron microscopy, in tunnelled cuffed catheters locked with three different solutions and to determine the relationship between these solutions and inflammatory response.
Study design:
This prospective study included 35 haemodialysis patients with tunnelled cuffed catheter removal for non–infection-related reasons. The participants were divided into three groups according to the lock solution used: (1) heparin 1: 5000 IU; (2) citrate 4%; and (3) taurolidine 1.35%, citrate 4% and heparin 500 IU (taurolock); in the latter group, 25,000 IU taurolidine–urokinase was used in the last weekly session. All tunnelled cuffed catheters were cultured, and the inner surface was evaluated with confocal and electron microscopy. The inflammatory profile of included patients was determined at tunnelled cuffed catheter removal.
Results:
There were no differences in clinical or demographic variables between the three subgroups. Biofilm thickness was lower in the taurolidine group than in the citrate 4% and heparin groups (28.85 ± 6.86 vs 49.99 ± 16.56 vs 56.2 ± 15.67 µm, respectively; p < 0.001), as was biofilm volume (1.01 ±1.18 vs 3.7 ± 2.15 vs 5.55 ±2.44, µm3, respectively; p < 0.001). The mean interleukin-6 value was 39%, which was 50% lower than in the citrate and heparin groups, but without significance differences.
Conclusion:
Our results show that biofilms were found in all tunnelled cuffed catheters, but the thickness and volume were significantly lower in tunnelled cuffed catheters locked with taurolidine solution. Therefore, the type of locking solution used in tunnelled cuffed catheters should maintain tunnelled cuffed catheter sterility and prevent catheter-related bloodstream infections. No significant difference was observed in the inflammatory profile according to the type of locking solution.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Infective Agents - administration & dosage</subject><subject>Anti-Infective Agents - adverse effects</subject><subject>Anticoagulants - administration & dosage</subject><subject>Anticoagulants - adverse effects</subject><subject>Biofilms - drug effects</subject><subject>Biofilms - growth & development</subject><subject>Catheter-Related Infections - diagnosis</subject><subject>Catheter-Related Infections - microbiology</subject><subject>Catheter-Related Infections - prevention & control</subject><subject>Catheters, Indwelling</subject><subject>Citric Acid - administration & dosage</subject><subject>Citric Acid - adverse effects</subject><subject>Equipment Design</subject><subject>Female</subject><subject>Heparin - administration & dosage</subject><subject>Heparin - adverse effects</subject><subject>Humans</subject><subject>Inflammation - blood</subject><subject>Inflammation - etiology</subject><subject>Inflammation - prevention & control</subject><subject>Inflammation Mediators - blood</subject><subject>Interleukin-6 - blood</subject><subject>Male</subject><subject>Microscopy, Confocal</subject><subject>Microscopy, Electron, Scanning</subject><subject>Middle Aged</subject><subject>Pilot Projects</subject><subject>Prospective Studies</subject><subject>Renal Dialysis - adverse effects</subject><subject>Renal Dialysis - instrumentation</subject><subject>Surface Properties</subject><subject>Taurine - administration & dosage</subject><subject>Taurine - adverse effects</subject><subject>Taurine - analogs & derivatives</subject><subject>Thiadiazines - administration & dosage</subject><subject>Thiadiazines - adverse effects</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1129-7298</issn><issn>1724-6032</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLtOwzAYhS0EoqWwMyGPLAHfEscjqrhUqsTSPbIdp3VJ7GInSH0CXhuHFgYkJl_OOd9vHwCuMbrDmPN7jIngRJQECUYQQydgijlhWYEoOU37JGejPgEXMW4RIiLH7BxMKCkELop8Cj4X3U7qHvoGtl6_WbeG0bdDb72L0DuovavteBoVZX1j2w42PnRyvITWwX5wzrStqeFGms7XVrb7aCPUst-Y3oQIpauTsWlll1I-7GEwcZf4BqbJ9uObdAnOGtlGc3VcZ2D19Liav2TL1-fF_GGZaUp5nwlCCce8JFxKhkuJa80KVVKpcqVzWtC85qWSzChS0JpimotGMWVobkST5Bm4PWB3wb8PJvZVZ6NOz5fO-CFWhJFcjDXRZEUHqw4-xmCaahdsJ8O-wqga26_-tp8iN0f6oDpT_wZ-6k6G7GCIcm2qrR-CS5_9H_gFjDuP1Q</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Jiménez Hernández, Mario</creator><creator>Soriano, Alex</creator><creator>Filella, Xavier</creator><creator>Calvo, María</creator><creator>Coll, Elisenda</creator><creator>Rebled, Josep M</creator><creator>Poch, Esteban</creator><creator>Graterol, Fredzia</creator><creator>Compte, María Teresa</creator><creator>Maduell, Francisco</creator><creator>Fontsere, Néstor</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3704-7318</orcidid></search><sort><creationdate>202105</creationdate><title>Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation</title><author>Jiménez Hernández, Mario ; Soriano, Alex ; Filella, Xavier ; Calvo, María ; Coll, Elisenda ; Rebled, Josep M ; Poch, Esteban ; Graterol, Fredzia ; Compte, María Teresa ; Maduell, Francisco ; Fontsere, Néstor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-9232717827aa418a1dc46b83ab5bc53635d78ba4eb263d31359fb4be35e9f363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Infective Agents - administration & dosage</topic><topic>Anti-Infective Agents - adverse effects</topic><topic>Anticoagulants - administration & dosage</topic><topic>Anticoagulants - adverse effects</topic><topic>Biofilms - drug effects</topic><topic>Biofilms - growth & development</topic><topic>Catheter-Related Infections - diagnosis</topic><topic>Catheter-Related Infections - microbiology</topic><topic>Catheter-Related Infections - prevention & control</topic><topic>Catheters, Indwelling</topic><topic>Citric Acid - administration & dosage</topic><topic>Citric Acid - adverse effects</topic><topic>Equipment Design</topic><topic>Female</topic><topic>Heparin - administration & dosage</topic><topic>Heparin - adverse effects</topic><topic>Humans</topic><topic>Inflammation - blood</topic><topic>Inflammation - etiology</topic><topic>Inflammation - prevention & control</topic><topic>Inflammation Mediators - blood</topic><topic>Interleukin-6 - blood</topic><topic>Male</topic><topic>Microscopy, Confocal</topic><topic>Microscopy, Electron, Scanning</topic><topic>Middle Aged</topic><topic>Pilot Projects</topic><topic>Prospective Studies</topic><topic>Renal Dialysis - adverse effects</topic><topic>Renal Dialysis - instrumentation</topic><topic>Surface Properties</topic><topic>Taurine - administration & dosage</topic><topic>Taurine - adverse effects</topic><topic>Taurine - analogs & derivatives</topic><topic>Thiadiazines - administration & dosage</topic><topic>Thiadiazines - adverse effects</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiménez Hernández, Mario</creatorcontrib><creatorcontrib>Soriano, Alex</creatorcontrib><creatorcontrib>Filella, Xavier</creatorcontrib><creatorcontrib>Calvo, María</creatorcontrib><creatorcontrib>Coll, Elisenda</creatorcontrib><creatorcontrib>Rebled, Josep M</creatorcontrib><creatorcontrib>Poch, Esteban</creatorcontrib><creatorcontrib>Graterol, Fredzia</creatorcontrib><creatorcontrib>Compte, María Teresa</creatorcontrib><creatorcontrib>Maduell, Francisco</creatorcontrib><creatorcontrib>Fontsere, Néstor</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of vascular access</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiménez Hernández, Mario</au><au>Soriano, Alex</au><au>Filella, Xavier</au><au>Calvo, María</au><au>Coll, Elisenda</au><au>Rebled, Josep M</au><au>Poch, Esteban</au><au>Graterol, Fredzia</au><au>Compte, María Teresa</au><au>Maduell, Francisco</au><au>Fontsere, Néstor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation</atitle><jtitle>The journal of vascular access</jtitle><addtitle>J Vasc Access</addtitle><date>2021-05</date><risdate>2021</risdate><volume>22</volume><issue>3</issue><spage>370</spage><epage>379</epage><pages>370-379</pages><issn>1129-7298</issn><eissn>1724-6032</eissn><abstract>Introduction:
The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and potentially increase patients’ inflammatory response. These complications could be reduced by the use of locking solutions.
Objective:
To analyse biofilm formation, using confocal and electron microscopy, in tunnelled cuffed catheters locked with three different solutions and to determine the relationship between these solutions and inflammatory response.
Study design:
This prospective study included 35 haemodialysis patients with tunnelled cuffed catheter removal for non–infection-related reasons. The participants were divided into three groups according to the lock solution used: (1) heparin 1: 5000 IU; (2) citrate 4%; and (3) taurolidine 1.35%, citrate 4% and heparin 500 IU (taurolock); in the latter group, 25,000 IU taurolidine–urokinase was used in the last weekly session. All tunnelled cuffed catheters were cultured, and the inner surface was evaluated with confocal and electron microscopy. The inflammatory profile of included patients was determined at tunnelled cuffed catheter removal.
Results:
There were no differences in clinical or demographic variables between the three subgroups. Biofilm thickness was lower in the taurolidine group than in the citrate 4% and heparin groups (28.85 ± 6.86 vs 49.99 ± 16.56 vs 56.2 ± 15.67 µm, respectively; p < 0.001), as was biofilm volume (1.01 ±1.18 vs 3.7 ± 2.15 vs 5.55 ±2.44, µm3, respectively; p < 0.001). The mean interleukin-6 value was 39%, which was 50% lower than in the citrate and heparin groups, but without significance differences.
Conclusion:
Our results show that biofilms were found in all tunnelled cuffed catheters, but the thickness and volume were significantly lower in tunnelled cuffed catheters locked with taurolidine solution. Therefore, the type of locking solution used in tunnelled cuffed catheters should maintain tunnelled cuffed catheter sterility and prevent catheter-related bloodstream infections. No significant difference was observed in the inflammatory profile according to the type of locking solution.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>32691665</pmid><doi>10.1177/1129729820942040</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-3704-7318</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1129-7298 |
ispartof | The journal of vascular access, 2021-05, Vol.22 (3), p.370-379 |
issn | 1129-7298 1724-6032 |
language | eng |
recordid | cdi_proquest_miscellaneous_2425902953 |
source | MEDLINE; SAGE Journals Online |
subjects | Adult Aged Aged, 80 and over Anti-Infective Agents - administration & dosage Anti-Infective Agents - adverse effects Anticoagulants - administration & dosage Anticoagulants - adverse effects Biofilms - drug effects Biofilms - growth & development Catheter-Related Infections - diagnosis Catheter-Related Infections - microbiology Catheter-Related Infections - prevention & control Catheters, Indwelling Citric Acid - administration & dosage Citric Acid - adverse effects Equipment Design Female Heparin - administration & dosage Heparin - adverse effects Humans Inflammation - blood Inflammation - etiology Inflammation - prevention & control Inflammation Mediators - blood Interleukin-6 - blood Male Microscopy, Confocal Microscopy, Electron, Scanning Middle Aged Pilot Projects Prospective Studies Renal Dialysis - adverse effects Renal Dialysis - instrumentation Surface Properties Taurine - administration & dosage Taurine - adverse effects Taurine - analogs & derivatives Thiadiazines - administration & dosage Thiadiazines - adverse effects Time Factors Treatment Outcome |
title | Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T21%3A04%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20locking%20solutions%20on%20conditioning%20biofilm%20formation%20in%20tunnelled%20haemodialysis%20catheters%20and%20inflammatory%20response%20activation&rft.jtitle=The%20journal%20of%20vascular%20access&rft.au=Jim%C3%A9nez%20Hern%C3%A1ndez,%20Mario&rft.date=2021-05&rft.volume=22&rft.issue=3&rft.spage=370&rft.epage=379&rft.pages=370-379&rft.issn=1129-7298&rft.eissn=1724-6032&rft_id=info:doi/10.1177/1129729820942040&rft_dat=%3Cproquest_cross%3E2425902953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2425902953&rft_id=info:pmid/32691665&rft_sage_id=10.1177_1129729820942040&rfr_iscdi=true |